ARIADNE Clinical Trial (NCT06747091)
Adjuvant Ablation for PeRsistent AtrIal FibrillAtion Using Dual ENergy LatticE Tip Catheter: ARIADNE-Randomized Clinical Trial
🩺 Plain-English Summary (8th-Grade Level)
A prospective multi-arm parallel group randomized clinical trial to compare the efficacy of three ablation strategies in patients with persistent atrial fibrillation using using a lattice-tip catheter that can switch between RFA and PFA energy. The incremental benefit of posterior wall isolation (PWI) and mitral isthmus ablation may contribute to greater freedom from atrial fibrillation at twelve months.
Who can join: Review the eligibility criteria below.
Location: North Shore University Hospital — Manhasset, New York
Age range: 18 Years to 80 Years
🧪 Interventions in This Study
- Catheter Ablation (PROCEDURE)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- North Shore University Hospital — Manhasset, New York
- Long Island Jewish Medical Center — New Hyde Park, New York
- Kristie Coleman — New York, New York
📞 Contact the Study Coordinator
Phone: (212) 434-6500
Email: kcoleman1@Northwell.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Persistent Atrial Fibrillation
- Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias — Jonesboro, Arkansas
- Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation — Birmingham, Alabama
- SPHERE Per-AF Post-Approval Study — Birmingham, Alabama
- Correlation of the Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation Study — Ottawa, Ontario
- STOP Persistent AF PAS — Hartford, Connecticut
- REPRESENT-PF Registry — New York, New York
Explore by condition: All Persistent Atrial Fibrillation clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.